STAT

Purdue Pharma seeks to minimize its role in opioid crisis as it urges dismissal of Massachusetts suit

A lawyer for OxyContin maker Purdue Pharma said it was a "serious misconception" that the company created the opioid epidemic.

BOSTON — OxyContin maker Purdue Pharma on Friday sought to minimize its role both in the opioid addiction crisis and as a player in the painkiller industry as it asked a Massachusetts judge to dismiss a lawsuit from the state.

The state alleges the company’s deceptive marketing of its drugs spawned the opioid epidemic in Massachusetts, but a lawyer for the company pushed back against that claim.

“The notion that Purdue has created this epidemic is a serious misperception,” attorney Timothy Blank argued for Purdue.

The arguments in Suffolk County Superior Court are the latest turn in Massachusetts Attorney General Maura Healey’s lawsuit against Purdue, members of the Sackler family, who control the company, and executives and board members.

Judge Janet Sanders did not

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks